CUX1 and neoplasm: Next, loss of heterozygosity (LOH) analyses confirmed LOH at 7q22 in a subset of breast cancer, uterine leiomyoma, and ovarian cancer (88–91), suggesting that genes in this region including CUX1 may function as tumor suppressors.